NCT01128426View on ClinicalTrials.gov

Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers

CompletedOBSERVATIONAL
Enrollment

53,902

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Pneumococcal Disease
Interventions
OTHER

No Intervention

No Intervention

Trial Locations (1)

94612

Northern California Kaiser Permanente, Oakland

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

lead

Pfizer

INDUSTRY